{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "wsmg:health-sciences/medicine/nephrology/neph-018",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:53:50.000Z",
    "modified": "2026-01-13T13:26:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/nephrology",
    "subdomain": "glomerular-diseases",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Anti-GBM Disease (Goodpasture Syndrome)",
    "summary": "Anti-glomerular basement membrane (anti-GBM) disease is a rare autoimmune disorder caused by circulating antibodies against the alpha-3 chain of type IV collagen in glomerular and alveolar basement membranes. It presents as rapidly progressive glomerulonephritis (RPGN) with or without pulmonary hemorrhage (Goodpasture syndrome), requiring urgent plasmapheresis and immunosuppression.",
    "key_points": [
      "Pathognomonic: Linear IgG staining along GBM on immunofluorescence",
      "Target antigen: Alpha-3 chain of type IV collagen (Goodpasture antigen)",
      "Pulmonary-renal syndrome (Goodpasture syndrome) in 60-80% of cases",
      "Smoking increases risk of pulmonary hemorrhage in anti-GBM disease",
      "Treatment: Plasmapheresis (remove antibodies) + steroids + cyclophosphamide",
      "Prognosis depends on initial creatinine; dialysis-dependent at presentation = poor renal outcome"
    ],
    "statement": "Anti-GBM disease is a fulminant autoimmune condition causing crescentic glomerulonephritis with pathognomonic linear IgG deposition, often presenting with concurrent pulmonary hemorrhage, requiring emergency plasmapheresis and aggressive immunosuppression.",
    "explanation": {
      "intuition": "Imagine antibodies as 'missiles' that specifically target the 'mortar' (type IV collagen) holding the glomerular and alveolar 'bricks' together. The resulting damage is like a building's foundation crumbling - the kidney's filtering units and lungs' air-blood barrier both fail rapidly.",
      "key_insight": "The LINEAR pattern on immunofluorescence is PATHOGNOMONIC - this smooth, ribbon-like IgG staining along the entire GBM is unique to anti-GBM disease and instantly distinguishes it from granular patterns seen in immune complex diseases. Time is kidney - early treatment before creatinine rises significantly is crucial.",
      "technical_details": "The Goodpasture antigen is the non-collagenous domain 1 (NC1) of the alpha-3(IV) chain. This epitope is normally hidden within the collagen structure ('cryptic') but becomes exposed through environmental insults (infection, smoking, hydrocarbons). Antibody binding activates complement and recruits neutrophils, causing focal necrotizing GN with crescent formation."
    },
    "definitions_glossary": {
      "anti_GBM_disease": "Autoimmune disease with antibodies against glomerular basement membrane causing RPGN",
      "Goodpasture_syndrome": "Anti-GBM disease with concurrent pulmonary hemorrhage",
      "Goodpasture_antigen": "NC1 domain of alpha-3 chain of type IV collagen",
      "linear_IF_pattern": "Smooth ribbon-like immunofluorescence along GBM; pathognomonic for anti-GBM",
      "crescentic_GN": "Glomerulonephritis with cellular/fibrous crescents from Bowman's capsule proliferation",
      "RPGN": "Rapidly progressive glomerulonephritis with renal failure over days to weeks",
      "DAH": "Diffuse alveolar hemorrhage; life-threatening pulmonary bleeding",
      "pulmonary_renal_syndrome": "Combined pulmonary hemorrhage and glomerulonephritis",
      "plasmapheresis": "Procedure removing plasma (and antibodies) and replacing with albumin/FFP",
      "type_IV_collagen": "Network-forming collagen of basement membranes",
      "cryptic_epitope": "Antigenic site normally hidden in protein structure",
      "Alport_syndrome": "Inherited collagen IV disorder; anti-GBM can develop post-transplant"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "IgG autoantibodies bind NC1 domain of alpha-3(IV) collagen, activating complement C3 and recruiting neutrophils, causing focal necrotizing injury and crescent formation",
      "antigen_exposure": {
        "triggers": ["Cigarette smoking", "Hydrocarbon exposure", "Respiratory infections", "Cocaine inhalation"],
        "mechanism": "Environmental insults damage alveolar BM, exposing normally cryptic Goodpasture antigen"
      },
      "tissue_targets": {
        "kidney": "Glomerular basement membrane - alpha-3(IV) chain present in all glomeruli",
        "lung": "Alveolar basement membrane - alpha-3(IV) chain present; requires additional insult (smoking) for hemorrhage"
      },
      "double_positive_disease": {
        "definition": "20-30% have concurrent ANCA positivity (usually MPO-ANCA)",
        "implications": "May have better response to immunosuppression, higher relapse risk"
      }
    },
    "diagnostic_criteria": {
      "clinical_presentation": [
        "RPGN: Oliguria, edema, hypertension, active sediment",
        "Pulmonary hemorrhage: Hemoptysis, dyspnea, diffuse infiltrates",
        "Constitutional symptoms: Fatigue, weight loss, arthralgias"
      ],
      "laboratory_findings": [
        "Anti-GBM antibodies positive (ELISA, IIF)",
        "Elevated creatinine with active sediment",
        "Anemia (from hemorrhage and/or AKI)",
        "Low complement levels (C3, C4) possible"
      ],
      "renal_biopsy": {
        "light_microscopy": ["Focal or diffuse crescentic GN", "Fibrinoid necrosis", "Linear deposits along GBM"],
        "immunofluorescence": "Linear IgG along GBM (PATHOGNOMONIC); C3 often linear too",
        "electron_microscopy": "No electron-dense deposits; GBM disruption"
      },
      "pulmonary_evaluation": [
        "CXR: Bilateral alveolar infiltrates",
        "CT chest: Ground-glass opacities",
        "DLCO: Increased (blood in alveoli absorbs CO)",
        "BAL: Hemosiderin-laden macrophages"
      ]
    },
    "differential_diagnosis": [
      "ANCA-associated vasculitis (pauci-immune, granular IF)",
      "Lupus nephritis (full-house IF pattern)",
      "IgA nephropathy (mesangial IgA)",
      "Membranoproliferative GN (granular IF)",
      "Thrombotic microangiopathy"
    ],
    "treatment_options": {
      "acute_management": {
        "plasmapheresis": "Daily or every other day for 2-3 weeks until antibody negative; removes circulating anti-GBM",
        "immunosuppression": "Cyclophosphamide 2mg/kg/day + prednisone 1mg/kg/day",
        "supportive": "Dialysis if needed, PJP prophylaxis, transfusion for anemia"
      },
      "duration_and_monitoring": {
        "plasmapheresis": "Continue until anti-GBM antibody undetectable",
        "cyclophosphamide": "3-6 months",
        "steroids": "Taper over 6-9 months",
        "monitoring": "Weekly anti-GBM titers during treatment"
      },
      "prognosis_factors": {
        "favorable": ["Initial creatinine <5.7 mg/dL", "No dialysis at presentation", "<50% crescents on biopsy"],
        "unfavorable": ["Dialysis-dependent at presentation", "100% crescents", "Oliguria"]
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Anti-GBM Disease"
    },
    "altLabel": [
      {"@language": "en", "@value": "Goodpasture syndrome"},
      {"@language": "en", "@value": "Goodpasture disease"},
      {"@language": "en", "@value": "Anti-glomerular basement membrane disease"}
    ],
    "definition": {
      "@language": "en",
      "@value": "Autoimmune disease caused by antibodies against type IV collagen in glomerular and alveolar basement membranes, causing rapidly progressive glomerulonephritis and pulmonary hemorrhage"
    },
    "notation": "neph-018",
    "scopeNote": {
      "@language": "en",
      "@value": "Covers pathogenesis, diagnosis, and management of anti-GBM disease/Goodpasture syndrome"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/glomerulonephritis",
        "skos:prefLabel": "Glomerulonephritis"
      }
    ],
    "skos:narrower": [],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-019",
        "skos:prefLabel": "ANCA-Associated Vasculitis Renal"
      },
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-011",
        "skos:prefLabel": "Glomerulonephritis Overview"
      },
      {
        "@id": "wsmg:health-sciences/medicine/pulmonology/pulm-027",
        "skos:prefLabel": "Hemoptysis Evaluation"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Goodpasture_syndrome"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "77136001",
      "uri": "http://snomed.info/id/77136001",
      "description": "Goodpasture syndrome"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "M31.0",
      "uri": "http://hl7.org/fhir/sid/icd-10-cm/M31.0",
      "description": "Hypersensitivity angiitis/Goodpasture syndrome"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D019867",
      "uri": "http://id.nlm.nih.gov/mesh/D019867",
      "description": "Anti-Glomerular Basement Membrane Disease"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Describe the pathogenesis of anti-GBM disease including target antigen",
      "Recognize the pathognomonic linear IgG pattern on immunofluorescence",
      "Differentiate anti-GBM disease from ANCA-associated vasculitis",
      "Outline the treatment protocol including plasmapheresis timing",
      "Predict renal prognosis based on presenting creatinine and biopsy findings"
    ],
    "clinical_pearls": [
      "Linear IgG on IF = PATHOGNOMONIC for anti-GBM disease",
      "Smoking activates lung involvement - cessation mandatory",
      "Start plasmapheresis BEFORE biopsy results in classic presentation",
      "Creatinine >5.7 or dialysis-dependent = <10% renal recovery",
      "20-30% are 'double positive' with ANCA - may have better prognosis"
    ],
    "board_yield": "HIGH",
    "estimated_time": "25min",
    "target_audience": [
      "nephrology_fellows",
      "pulmonology_fellows",
      "internal_medicine_residents"
    ],
    "common_misconceptions": [
      "All anti-GBM patients have pulmonary hemorrhage - only 60-80%",
      "Dialysis at presentation = no hope - some recover with aggressive treatment",
      "Anti-GBM and ANCA are mutually exclusive - 20-30% are double positive"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/nephrology/neph-011",
      "skos:prefLabel": "Glomerulonephritis Overview"
    }
  ],
  "related_concepts": [
    "plasmapheresis",
    "immunofluorescence",
    "type IV collagen",
    "crescentic GN",
    "pulmonary hemorrhage"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "McAdoo SP, Pusey CD",
        "title": "Anti-Glomerular Basement Membrane Disease",
        "journal": "Clin J Am Soc Nephrol",
        "year": 2017,
        "volume": "12",
        "pages": "1162-1172",
        "doi": "10.2215/CJN.01380217"
      }
    ],
    "confidence_rationale": "Based on KDIGO guidelines and comprehensive reviews"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-13T13:26:00.000Z",
    "sources": [
      {
        "source": "KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases",
        "type": "guideline",
        "year": 2021,
        "relevance": "Evidence-based management of anti-GBM disease"
      },
      {
        "source": "Brenner and Rector's The Kidney, 11th ed. Elsevier, 2020.",
        "type": "textbook",
        "year": 2020,
        "isbn": "978-0323532655",
        "relevance": "Comprehensive nephrology reference"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.95,
    "completeness": 0.96,
    "accuracy": 0.97,
    "clarity": 0.94,
    "clinical_relevance": 0.98,
    "last_assessed": "2026-01-13T13:26:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Goodpasture_syndrome",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1194951"
}